STRAHLENTHERAPIE UND ONKOLOGIE

Scope & Guideline

Unveiling the future of cancer treatment and radiation therapy.

Introduction

Welcome to the STRAHLENTHERAPIE UND ONKOLOGIE information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of STRAHLENTHERAPIE UND ONKOLOGIE, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageMulti-Language
ISSN0179-7158
PublisherSPRINGER HEIDELBERG
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1986 to 2024
AbbreviationSTRAHLENTHER ONKOL / Strahlenther. Onkol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY

Aims and Scopes

The journal 'STRAHLENTHERAPIE UND ONKOLOGIE' focuses on advancing the field of radiation therapy and oncology through a diverse range of research topics. It aims to publish high-quality studies that contribute to the understanding and application of radiotherapy in various cancer types, emphasizing the integration of innovative technologies and treatment modalities.
  1. Radiotherapy Techniques and Innovations:
    The journal consistently publishes research on novel radiotherapy techniques, including intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), and proton therapy, highlighting advancements that improve treatment precision and patient outcomes.
  2. Clinical Outcomes and Toxicity Management:
    A significant focus is placed on clinical studies that evaluate the effectiveness of various treatment regimens, including chemoradiotherapy, and their associated toxicities, with an emphasis on optimizing patient care and quality of life.
  3. Personalized and Adaptive Radiotherapy:
    Research exploring personalized treatment approaches, including the use of AI in treatment planning and adaptive radiotherapy techniques, is a core area of interest, addressing the need for tailored therapies based on individual patient characteristics.
  4. Integration of Imaging and Radiomics:
    The journal highlights the role of advanced imaging techniques, such as PET/CT and MRI, along with radiomics, in predicting treatment responses and outcomes, illustrating the growing intersection between imaging and radiotherapy.
  5. Multidisciplinary Approaches and Patient-Centered Care:
    Emphasizing the importance of a multidisciplinary approach, the journal features studies that integrate insights from various specialties, including oncology, surgery, and palliative care, to enhance patient management and treatment strategies.
The journal is witnessing a dynamic evolution in its research themes, with several emerging trends that reflect the latest advancements and priorities in the field of radiation oncology. This section outlines the currently trending research areas.
  1. Artificial Intelligence and Machine Learning:
    There is a growing trend towards the application of AI and machine learning techniques in radiation therapy, from treatment planning to predictive modeling, enhancing precision and efficiency in patient management.
  2. Immunotherapy and Radiotherapy Combinations:
    Research exploring the synergistic effects of combining immunotherapy with radiotherapy is on the rise, reflecting a shift towards integrated treatment strategies that optimize clinical outcomes for cancer patients.
  3. Patient-Centered Approaches and Quality of Life Assessments:
    Increasing attention is being paid to patient-reported outcomes and quality of life assessments in treatment protocols, emphasizing the importance of patient perspectives and experiences in oncology care.
  4. Real-World Data and Comparative Effectiveness Research:
    There is a notable trend towards utilizing real-world data to assess treatment effectiveness and safety, providing insights that complement clinical trial findings and inform clinical practice.
  5. Sustainability and Cost-Effectiveness in Oncology:
    Emerging themes around sustainability in radiation oncology practices and the evaluation of cost-effectiveness of various treatment modalities are gaining traction, reflecting broader healthcare priorities.

Declining or Waning

While the journal continues to thrive in various research areas, some themes appear to be losing prominence in recent publications. This section identifies these waning scopes, reflecting shifts in research focus within the field of radiation oncology.
  1. Traditional Radiation Techniques:
    There is a noticeable decline in studies focusing solely on conventional radiation therapy methods without the integration of advanced technologies or personalized approaches, as the field shifts towards more innovative and tailored treatment strategies.
  2. Descriptive Studies without Clinical Application:
    Research that is primarily descriptive and lacks direct clinical application or implications seems to be decreasing, as the journal increasingly favors studies that demonstrate practical outcomes and advancements in patient care.
  3. Longitudinal Studies on Historical Data:
    The emphasis on historical data analysis and retrospective studies without new insights or technological advancements appears to be waning, with a greater focus now on contemporary clinical trials and innovative methodologies.

Similar Journals

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Shaping the Future of Cancer Care
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0277-3732Frequency: 12 issues/year

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, published by Lippincott Williams & Wilkins, is a pivotal journal in the fields of oncology and cancer research, focusing on the latest advancements in clinical trials and therapeutic strategies for cancer management. With an ISSN of 0277-3732 and an E-ISSN of 1537-453X, this journal serves as an essential resource for the dissemination of high-quality research findings, scholarly reviews, and innovative methodologies, aiming to advance clinical oncology from 1982 to 2024. It is categorized in Q3 for Cancer Research and Q2 for Oncology, reflecting its significant role in the scientific community. In addition to its rigorous peer-reviewed content, the journal provides a platform for researchers and clinicians to share valuable insights, laying the groundwork for future breakthroughs in cancer treatment. Although it currently does not offer open-access options, the journal remains accessible to a wide audience through academic institutions and libraries. The AMERICAN JOURNAL OF CLINICAL ONCOLOGY is crucial for anyone involved in oncology research, making it a must-read for professionals dedicated to improving cancer care.

Journal of Contemporary Brachytherapy

Empowering oncologists with cutting-edge brachytherapy insights.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1689-832XFrequency: 6 issues/year

Journal of Contemporary Brachytherapy, published by TERMEDIA PUBLISHING HOUSE LTD, is a distinguished open-access journal dedicated to advancing the field of brachytherapy within the oncology and radiology domains. Since its inception in 2009, the journal has provided a platform for researchers, clinicians, and students to share innovative findings, cutting-edge techniques, and clinical experiences, contributing significantly to evidence-based practices in cancer treatment. With an ISSN of 1689-832X and E-ISSN 2081-2841, the journal has established its presence globally, and it is indexed in Scopus, achieving a commendable standing among its peers—with rankings of #196 in Radiology, Nuclear Medicine, and Imaging and #260 in Oncology for 2023. Notably, it holds a Q3 quartile classification, reflecting its emerging influence in these critical fields. The journal is committed to open science, ensuring that research is accessible to a wide audience, which is particularly vital for the ongoing development of methodologies and the implementation of best practices in brachytherapy. Exploring topics from the technical aspects of brachytherapy procedures to patient management strategies, the Journal of Contemporary Brachytherapy is an essential resource for those looking to stay at the forefront of oncological advancements.

Physics & Imaging in Radiation Oncology

Elevating Standards in Radiation Therapy with Advanced Imaging Solutions
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Physics & Imaging in Radiation Oncology is a premier journal dedicated to advancing the interdisciplinary field of radiation oncology through innovative research and imaging technologies. Published by Elsevier, this open-access journal has made its mark since its inception in 2017, ensuring that groundbreaking findings are accessible to a broad audience. With a strong focus on the integration of physics, imaging techniques, and oncology, the journal occupies esteemed positions in the academic landscape, ranking in the top quartile for Radiation and Radiology, Nuclear Medicine and Imaging as of 2023. The journal serves as a platform for researchers, professionals, and students to share insights and foster collaboration, ultimately improving patient outcomes through enhanced imaging and treatment modalities. Based in Ireland and operating from Radarweg 29, 1043 NX Amsterdam, Netherlands, the journal aims to bridge the gap between theoretical physics and practical applications in clinical settings.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Elevating Standards in Radiation Oncology and Biology.
Publisher: ELSEVIER SCIENCE INCISSN: 0360-3016Frequency: 15 issues/year

International Journal of Radiation Oncology Biology Physics, published by Elsevier Science Inc, is a premier academic journal that has played a critical role in advancing the field of radiation oncology since its inception in 1975. With an impressive impact factor and recognition as a Q1 journal across multiple categories such as Cancer Research, Oncology, and Radiology, this journal serves as a vital resource for researchers, clinicians, and students dedicated to understanding and improving cancer treatment modalities. Its multifaceted scope encompasses original research, reviews, and innovative clinical studies, fostering a deeper understanding of the interplay between radiation, biology, and oncology. With a remarkable ranking in Scopus, including a top position in Radiation Physics and an elite percentile in Oncology, IJROBP remains at the forefront of scientific discovery and innovation in the management of cancer. A traditional subscription model ensures high-quality, peer-reviewed content, providing invaluable insights that continue to advance the standards of care and research in radiation oncology.

Breast Journal

Elevating standards in oncology and surgery for breast health.
Publisher: WILEY-HINDAWIISSN: 1075-122XFrequency: 1 issue/year

The Breast Journal, published by Wiley-Hindawi, is a distinguished Open Access journal dedicated to the fields of internal medicine, oncology, and surgery with a particular focus on breast health and disease. Since its inception in 1995, the journal has become an essential resource for researchers and clinicians, facilitating the dissemination of high-quality research and innovative clinical practices. With an impact factor reflecting robust scholarly influence and a ranking in the Q3 quartile for both internal medicine and oncology, as well as Q2 in surgery, it showcases significant contributions that advance knowledge and improve patient outcomes. Offering unparalleled access to its articles, The Breast Journal aims to support a global audience in exploring the multifaceted challenges and breakthroughs in breast-related health, making it a vital platform for shared learning and scientific discourse.

CLINICAL ONCOLOGY

Driving Innovation in Oncology and Imaging for Better Health
Publisher: ELSEVIER SCIENCE LONDONISSN: 0936-6555Frequency: 6 issues/year

Clinical Oncology is a prestigious peer-reviewed journal published by Elsevier Science London, focusing on the dynamic fields of Oncology and Radiology, Nuclear Medicine, and Imaging. With an impressive impact factor reflecting its high-quality research contributions, the journal is ranked in the second quartile for oncology and the first quartile for radiology, underscoring its importance in advancing clinical knowledge and practice. Established in 1975, Clinical Oncology offers researchers, healthcare professionals, and students robust access to cutting-edge studies, reviews, and clinical trials that drive innovation and improve patient care. Based in the United Kingdom, the journal plays a vital role in disseminating significant findings, fostering collaboration, and enhancing education in the biosciences, particularly for those committed to addressing the challenges in cancer treatment and diagnostics. Given its rigorous selection criteria and broad readership, Clinical Oncology remains an essential resource for anyone dedicated to the fields of oncology and radiology.

Turk Onkoloji Dergisi-Turkish Journal of Oncology

Advancing cancer research through collaboration and insight.
Publisher: KARE PUBLISSN: 1300-7467Frequency: 4 issues/year

Turk Onkoloji Dergisi - Turkish Journal of Oncology, published by KARE PUBL, serves as a vital platform in the field of oncology, specifically catering to the Turkish-speaking research community and contributing to global discourse. With an ISSN of 1300-7467, this journal, which has been in circulation since 2007 and continues until 2024, recognizes the importance of advancing medical knowledge in cancer research through rigorous peer-reviewed articles. Although currently positioned in the Q4 category of oncology journals with a Scopus rank of #344 out of 404, the journal is dedicated to fostering significant research insights and innovative perspectives on cancer treatment and prevention. While it does not currently offer open access, its content is essential for professionals, researchers, and students aiming to enhance their understanding of oncology developments in Turkey and beyond. The Turkish Journal of Oncology not only aspires to improve the quality of cancer care but also strives to enhance collaboration among researchers, thereby influencing future oncology practices.

Journal of Radiosurgery and SBRT

Bridging Science and Practice in SBRT
Publisher: OLD CITY PUBLISHING INCISSN: 2156-4639Frequency: 4 issues/year

Journal of Radiosurgery and SBRT is a dedicated platform for advancing the field of radiosurgery and stereotactic body radiation therapy (SBRT), published by OLD CITY PUBLISHING INC. With its ISSN 2156-4639 and E-ISSN 2156-4647, this journal serves researchers and practitioners keen on the latest findings and methodologies in the domains of radiological technology and surgical oncology. Operating from Spain, the journal has established itself within notable quartiles, ranking Q3 in 2023 across categories including Radiological and Ultrasound Technology, Radiology, Nuclear Medicine and Imaging, and Surgery. The journal is indexed in Scopus, with rankings that place it at #311 in Medicine Surgery and #232 in Medicine Radiology categories, reflecting its significance in the academic community. Although it does not currently offer an open-access model, the Journal of Radiosurgery and SBRT aims to foster innovation and collaboration, making it an essential resource for those involved in cutting-edge research and clinical practice in radiosurgery.

RADIOTHERAPY AND ONCOLOGY

Advancing cancer care through groundbreaking research.
Publisher: ELSEVIER IRELAND LTDISSN: 0167-8140Frequency: 12 issues/year

Radiotherapy and Oncology is a leading peer-reviewed journal published by Elsevier Ireland Ltd, focusing on the vital fields of hematology, oncology, and radiology. With an impressive impact factor and ranking in the top quartiles (Q1) of its categories as of 2023, it is recognized for disseminating high-quality research that contributes significantly to advancements in cancer treatment and patient care. The journal, which has been in circulation since 1983, aims to provide a platform for original research articles, reviews, and clinical studies that explore the latest innovations in radiotherapeutic technologies and oncology practices. This journal is essential for researchers, healthcare professionals, and students who are dedicated to improving cancer therapies and outcomes. Although it does not offer open access, the wealth of information contained within its pages supports continued education and development in these crucial medical fields.

RADIATION RESEARCH

Advancing knowledge in radiation science and health.
Publisher: RADIATION RESEARCH SOCISSN: 0033-7587Frequency: 12 issues/year

RADIATION RESEARCH is a prestigious journal published by the RADIATION RESEARCH SOC that serves as a vital resource for professionals and researchers in the fields of biophysics, radiation science, and radiology. Established in 1954, this journal has consistently advanced the study of radiation's effects on health and the environment, bridging fundamental and applied research. It boasts an impressive impact factor reflected in its quartile rankings, including Q2 in Biophysics and Q1 in Radiation, making it a highly regarded publication within its discipline. Researchers will find valuable insights through rigorous peer-reviewed articles that explore innovative methodologies and findings related to radiation exposure, imaging technologies, and the biological consequences of radiation. Although the journal does not currently offer open access, it remains a vital reference for academia and industry, fostering a deeper understanding of radiation sciences and their implications for future research and public health.